Funded by The Sontag Foundation, William Flavahan, PhD, will examine the role epigenetic defects play in the initiation and treatment-resistance of primary pediatric glioma, the number one cause of cancer deaths in children: bit.ly/3GhQNLX #BrainCancer #CancerResearch @UMassMedMCCB

Only 10 percent of #pancreaticcancer patients will survive for an average of five years after diagnosis. Brian Lewis, PhD, likens the process of developing new novel therapies to an old way of treating HIV patients: bit.ly/3GLfktj #CommunicatingScience UMass Chan Institute for Drug Resistance

A Research Associate II position is available at UMass Chan Medical School. The Kelliher lab studies how leukemia develops using genetically engineered mouse models and patient derived xenografts. More information is available at ummsjobs.com/job/6646/

MCCB has some great job opportunities open right now. Come join a great team! umassmed.edu/mccb/job-oppor…

Congratulations to Michelle Kelliher , co-leader of the Cancer Genetics Program, for being named the inaugural Our Danny Cancer Fund Chair in Biomedical Research. The endowed chair marks her important contributions to cancer biology. umassmed.edu/cancer-center/… #cancertherapeutics

Eric Baehrecke, PhD, professor of molecular, cell & cancer biology; Jeanne Lawrence, PhD, professor of neurology and pediatrics; and Alan Mullen, MD, PhD, professor of medicine and academic chief of gastroenterology, now hold named chairs: bit.ly/3Q8xuKM Eric H. Baehrecke

Dr. Leslie Shaw and co-authors at UMass Chan Medical School reported that #insulin/IGF signaling supported #BreastCancer stem cell self-renewal and regulated stemness in an IRS2- and PI3K-dependent manner. Cell Reports | bit.ly/3HsAwYr

Sharon B. Cantor, PhD, professor of molecular, cell & cancer biology, has been appointed to the Gladys Smith Martin Chair in Oncology, an endowment to support a faculty member whose research is focused on preventing, treating and curing cancer. umassmed.edu/news/news-arch…

It is with deep sadness that we share Michael Green, MD, PhD, has died. Please honor his legacy by reading about his work as one of the most distinguished biomedical research leaders in our academic community and across the nation: direc.to/iF8P

The Diversity and Inclusion Office is celebrating Black History Month by amplifying the voices of Black scientists UMass Chan Medical School. Brian Lewis, PhD, led an in-depth discussion on Wednesday about his research and how to make room for diversity, equity and inclusion through science.

Jonathan M. Gerber, MD, will succeed the late Michael Green, MD, PhD, as director of the UMass Cancer Center, and Michelle A. Kelliher, PhD, will serve as interim chair of the Department of Molecular, Cell & Cancer Biology. direc.to/iAdQ Michelle Kelliher Molecular, Cell and Cancer Biology

Read this blog post to learn about the novel way that Marcus Ruscetti Lab, Loretah Chibaya, PhD, and the rest of the team revved up the immune system in #pancreaticcancer. This impressive study was published in Nature Cancer! UMass Chan Medical School #senescence #NKcells umassmed.edu/cancer-center/…

Congrats James Shen for receiving the Dean’s Award for Outstanding Thesis Research for his dissertation work on the essential role of membrane interactions that unite autophagy w/ mitochondrial dynamics in both normally functioning cells & human disease in the Eric H. Baehrecke

Join us September 24, 2023 for the UMass Cancer Walk. Join our team! p2p.onecause.com/umasscancerwal…

MD/PhD student Ayush Kumar has just received funding from National Cancer Institute to study triple-negative breast cancer: direc.to/jxcD “A lot of patients have relapsed. Hopefully, we can identify how we can incorporate newer therapies to prevent that.” Mercurio Lab UMass Chan MD/PhD Program

Thrilled to share our recent paper published online Cell Reports led by our graduate student Dimpi Dimpi Mukhopadhyay PhD 🏳️‍🌈 🎉 UMass Chan Medical School UMass Cancer Center Molecular, Cell and Cancer Biology Morningside Graduate School of Biomedical Sciences cell.com/cell-reports/f…

In a new #VoicesofUMassChan #podcast, Marcus Ruscetti, PhD, said he initially tried not take after his scientist parents. Listen to the full podcast about Dr. Ruscetti's prostate cancer research on Jan. 31: direc.to/kSVm Marcus Ruscetti Lab Molecular, Cell and Cancer Biology UMass Cancer Center

Three scientists at UMass Chan Medical School were awarded $2.3M in new funding from RSRT to utilize base-editing and prime-editing technologies to correct mutations in MECP2: umassmed.edu/news/news-arch… RNA Therapeutics Institute Molecular, Cell and Cancer Biology